NCT02470611

Brief Summary

In the past few years, studies have evaluated the effect of systemic use of sodium alendronate, especially in the treatment of structural bone defects caused by periodontal diseases. This study evaluated the effects of non-surgical periodontal treatment associated with the topical application of 1% sodium alendronate on clinical and topographical parameters. Chronic periodontitis patients were recruited for the present study and were monitored at 3 and 6 months after baseline examinations. A placebo gel was used as control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Nov 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 12, 2015

Completed
Last Updated

June 12, 2015

Status Verified

June 1, 2015

Enrollment Period

1 year

First QC Date

June 2, 2015

Last Update Submit

June 9, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in pocket depth

    Reductions in pocket depth overtime

    baseline and 3- and to 6-month evaluations

  • Changes in clinical attachment level

    Gain in clinical attachment level overtime

    baseline and 3- and to 6-month evaluations

Secondary Outcomes (1)

  • Changes in bone defects

    Baseline and 6 months

Study Arms (2)

Sodium Alendronate

EXPERIMENTAL

Adjunctive use of 1% sodium alendronate gel as part of periodontitis treatment

Drug: Sodium alendronate

Placebo

PLACEBO COMPARATOR

Adjunctive use of placebo gel as part of periodontitis treatment

Other: Placebo

Interventions

After manual quadrant-wise scaling and root planing, at the final treatment appointment the randomized selected periodontal site (showing pocket depth ≥ 5mm, clinical attachment loss \> 3mm and proximal bone defects) received 1% sodium alendronate gel

Also known as: biphosphonates
Sodium Alendronate
PlaceboOTHER

After manual quadrant-wise scaling and root planing, at the final treatment appointment the randomized selected periodontal site (showing pocket depth ≥ 5mm, clinical attachment loss \> 3mm and proximal bone defects) received 1% placebo gel

Placebo

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • chronic periodontitis
  • two contralateral teeth showing periodontal pocket depth ≥ 5mm, clinical attachment loss \> 3mm, proximal vertical bone defects, no prosthetic device, without caries lesions, proximal dental contact and lack of premature occlusal contact
  • systemically healthy volunteers

You may not qualify if:

  • need for antibiotic or systemic/local antibiotic use in the previous 3 months
  • periodontal treatment in the previous 6 months
  • pregnancy or lactation
  • immunological disorders or imune suppressive treatments
  • diabetes
  • smoking
  • orthodontic appliances or removable prosthesis
  • osteoporosis
  • known or suspected allergy to biphosphonates
  • systemic use of biphosphonates

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental clinic of pontifical catholic university

Belo Horizonte, Minas Gerais, Brazil

Location

MeSH Terms

Conditions

PeriodontitisBone Resorption

Interventions

AlendronateDiphosphonates

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

OrganophosphonatesOrganophosphorus CompoundsOrganic Chemicals

Study Officials

  • Fernando O Costa, PhD

    Head of Periodontology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical evaluation and treatment for the effect of image periodontal mechanical non surgical associated with application of topical alendronate sodium a 1% repair periodontal: randomized controlled clinical trial

Study Record Dates

First Submitted

June 2, 2015

First Posted

June 12, 2015

Study Start

November 1, 2012

Primary Completion

November 1, 2013

Study Completion

November 1, 2014

Last Updated

June 12, 2015

Record last verified: 2015-06

Locations